Tapewire

NYSE · USD

HUM

HUMANA INC

Export transactions ↓
Tapewire entity
1429
SEC CIK
0000049071
Parsed reports
738

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202610
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 18, 2017 Filed Feb 22, 2017 23:47 UTC
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
Exercise / conversionHumana Common 10,651 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000030 · edgar.xml · nonDerivative · entry 1

BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,439

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · shares: Includes both time based (3,304) and performance based (7,347) restricted stock units that vested on 2/18/2017.

Read SEC document
February 18, 2017 Filed Feb 22, 2017 23:43 UTC
BROUSSARD BRUCE DDirector · President & CEO
Exercise / conversionRestricted Stock Units · Derivative 16,519 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000029 · edgar.xml · derivative · entry 11

BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 16,519 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6 · derivative.exercise_date: Restricted stock units granted to Reporting Person on 02/18/2014, 100% of the award is vesting on 02/18/17.

F6 · derivative.expiration_date: Restricted stock units granted to Reporting Person on 02/18/2014, 100% of the award is vesting on 02/18/17.

Read SEC document
February 18, 2017 Filed Feb 22, 2017 23:43 UTC
BROUSSARD BRUCE DDirector · President & CEO
Tax withholdingHumana Common 25,413 $205.33 $5,217,924.23
Disclosure

SEC source: 0000049071-17-000029 · edgar.xml · nonDerivative · entry 2

BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,695

Read SEC document
February 18, 2017 Filed Feb 22, 2017 23:43 UTC
BROUSSARD BRUCE DDirector · President & CEO
Exercise / conversionHumana Common 53,257 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000029 · edgar.xml · nonDerivative · entry 1

BROUSSARD BRUCE D · CIK 0001185643 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,108

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · shares: Includes both time based (16,519) and performance based (36,738) based restricted stock units that vested on 2/18/17.

Read SEC document
January 06, 2017 Filed Jan 10, 2017 18:48 UTC
HUNTER CHRISTOPHER H.SVP and Chief Strategy Officer
Exercise / conversionRestricted Stock Units · Derivative 14,827 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000011 · edgar.xml · derivative · entry 6

HUNTER CHRISTOPHER H. · CIK 0001595519 · SVP and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 14,827 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under Company's 2011 Plan.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3) under Company's 2011 Plan.

F5 · derivative.exercise_date: Restricted stock units granted to Reporting Person on 01/06/14, 100% of the award is vesting on 01/06/17.

F5 · derivative.expiration_date: Restricted stock units granted to Reporting Person on 01/06/14, 100% of the award is vesting on 01/06/17.

Read SEC document
January 06, 2017 Filed Jan 10, 2017 18:48 UTC
HUNTER CHRISTOPHER H.SVP and Chief Strategy Officer
Tax withholdingHumana Common 6,576 $201.25 $1,323,436.44
Disclosure

SEC source: 0000049071-17-000011 · edgar.xml · nonDerivative · entry 2

HUNTER CHRISTOPHER H. · CIK 0001595519 · SVP and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,966

Read SEC document
January 06, 2017 Filed Jan 10, 2017 18:48 UTC
HUNTER CHRISTOPHER H.SVP and Chief Strategy Officer
Exercise / conversionHumana Common 14,827 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000011 · edgar.xml · nonDerivative · entry 1

HUNTER CHRISTOPHER H. · CIK 0001595519 · SVP and Chief Strategy Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,542

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 03, 2017 Filed Jan 4, 2017 21:49 UTC GrantHumana Common 761 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000009 · edgar.xml · nonDerivative · entry 1

Dunbar Webster Roy · CIK 0001305807 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,166

F4 · balance_after: Includes 761 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan of which 100% is vesting on 12/31/2017.

Read SEC document
January 03, 2017 Filed Jan 4, 2017 21:47 UTC GrantHumana Common 761 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000008 · edgar.xml · nonDerivative · entry 1

OBRIEN JAMES J /KY · CIK 0001023582 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,361

F3 · balance_after: Includes 761 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan of which 100% is vesting on 12/31/2017.

Read SEC document
January 03, 2017 Filed Jan 4, 2017 21:45 UTC GrantRestricted Stock Units · Derivative 761 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000007 · edgar.xml · derivative · entry 4

MITCHELL WILLIAM · CIK 0001187421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 761

Underlying: Humana Common · 761 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017.

F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017.

F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017.

Read SEC document
January 03, 2017 Filed Jan 4, 2017 21:38 UTC GrantRestricted Stock Units · Derivative 761 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000006 · edgar.xml · derivative · entry 5

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 761

Underlying: Humana Common · 761 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017.

F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017.

F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017.

Read SEC document
January 03, 2017 Filed Jan 4, 2017 21:34 UTC GrantHumana Common 761 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000005 · edgar.xml · nonDerivative · entry 1

PETERSON MARISSA T · CIK 0001220067 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,066

F3 · balance_after: Includes 761 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan of which 100% is vesting on 12/31/2017.

Read SEC document
January 03, 2017 Filed Jan 4, 2017 21:31 UTC
NASH DAVIDDirector
GrantRestricted Stock Units · Derivative 761 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000004 · edgar.xml · derivative · entry 4

NASH DAVID · CIK 0001251968 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 761

Underlying: Humana Common · 761 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017.

F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017.

F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017.

Read SEC document
January 03, 2017 Filed Jan 4, 2017 21:21 UTC GrantHumana Common 761 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000003 · edgar.xml · nonDerivative · entry 1

JONES DAVID A JR/KY · CIK 0001025393 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 761

F8 · balance_after: Includes 761 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan of which 100% is vesting on 12/31/2017.

Read SEC document
January 03, 2017 Filed Jan 4, 2017 21:18 UTC GrantRestricted Stock Units · Derivative 761 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000002 · edgar.xml · derivative · entry 7

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 761

Underlying: Humana Common · 761 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017.

F5 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017.

F5 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2017.

Read SEC document
January 03, 2017 Filed Jan 4, 2017 21:11 UTC GrantRestricted Stock Units · Derivative 761 $0.00 $0.00
Disclosure

SEC source: 0000049071-17-000001 · edgar.xml · derivative · entry 5

McDonald William J. · CIK 0001415604 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 761

Underlying: Humana Common · 761 shares

Expires not disclosed

F1 · derivative.exercise_price: Annual Director's fee payable in stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2011 Plan.100% of the award is vesting on 12/31/2017.

F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2011 Plan.100% of the award is vesting on 12/31/2017.

F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2011 Plan.100% of the award is vesting on 12/31/2017.

Read SEC document
January 02, 2017 Filed Jan 3, 2018 21:11 UTC GrantRestricted Stock Units · Derivative 658 $0.00 $0.00
Disclosure

SEC source: 0000049071-18-000010 · edgar.xml · derivative · entry 4

MITCHELL WILLIAM · CIK 0001187421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 658

Underlying: Humana Common · 658 shares

Expires not disclosed

F3 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018.

F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018.

F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018.

F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018.

Read SEC document
January 02, 2017 Filed Jan 3, 2018 20:59 UTC GrantStock Unit · Derivative 658 $0.00 $0.00
Disclosure

SEC source: 0000049071-18-000005 · edgar.xml · derivative · entry 7

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 658

Underlying: Humana Common · 658 shares

Expires not disclosed

F5 · security: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018.

F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018.

F5 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018.

F5 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2018.

Read SEC document
December 31, 2016 Filed Jan 4, 2017 21:52 UTC OtherPhantom Stock Units · Derivative 6 $171.06 $1,026.36
Disclosure

SEC source: 0000049071-17-000010 · edgar.xml · derivative · entry 12

MURRAY JAMES E · CIK 0001018658 · EVP & COO

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 3,808

Underlying: Humana Common · 6 shares

Expires not disclosed

F11 · security: Phantom Stock Units (based on the value of Humana common stock) held for the benefit of reporting person as of December 31, 2016, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivilents. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of October 28, 2016.

F11 · derivative.exercise_price: Phantom Stock Units (based on the value of Humana common stock) held for the benefit of reporting person as of December 31, 2016, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivilents. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of October 28, 2016.

F11 · derivative.exercise_date: Phantom Stock Units (based on the value of Humana common stock) held for the benefit of reporting person as of December 31, 2016, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivilents. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of October 28, 2016.

F11 · derivative.expiration_date: Phantom Stock Units (based on the value of Humana common stock) held for the benefit of reporting person as of December 31, 2016, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivilents. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of October 28, 2016.

F11 · ownership.nature: Phantom Stock Units (based on the value of Humana common stock) held for the benefit of reporting person as of December 31, 2016, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price. Transaction reported reflects shares acquired for a quarterly allocation of dividend equivilents. The amount of shares purchased was determined using the closing price of Humana stock on the dividend payable date of October 28, 2016.

Read SEC document
December 31, 2016 Filed Jan 4, 2017 21:49 UTC GrantStock Unit · Derivative 132 $203.53 $26,865.96
Disclosure

SEC source: 0000049071-17-000009 · edgar.xml · derivative · entry 4

Dunbar Webster Roy · CIK 0001305807 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 842

Underlying: Humana Common · 132 shares

Expires not disclosed

F3 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2016 Filed Jan 4, 2017 21:45 UTC GrantStock Unit · Derivative 91 $203.53 $18,521.23
Disclosure

SEC source: 0000049071-17-000007 · edgar.xml · derivative · entry 3

MITCHELL WILLIAM · CIK 0001187421 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 789

Underlying: Humana Common · 91 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2016 Filed Jan 4, 2017 21:38 UTC GrantStock Unit · Derivative 376 $203.53 $76,527.28
Disclosure

SEC source: 0000049071-17-000006 · edgar.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,824

Underlying: Humana Common · 376 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
December 31, 2016 Filed Jan 4, 2017 21:38 UTC GrantStock Unit · Derivative 144 $203.53 $29,308.32
Disclosure

SEC source: 0000049071-17-000006 · edgar.xml · derivative · entry 3

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 689

Underlying: Humana Common · 144 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2016 Filed Jan 4, 2017 21:31 UTC
NASH DAVIDDirector
GrantStock Unit · Derivative 71 $203.53 $14,450.63
Disclosure

SEC source: 0000049071-17-000004 · edgar.xml · derivative · entry 3

NASH DAVID · CIK 0001251968 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 420

Underlying: Humana Common · 71 shares

Expires not disclosed

F2 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F2 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2016 Filed Jan 4, 2017 21:11 UTC GrantStock Unit · Derivative 143 $203.53 $29,104.79
Disclosure

SEC source: 0000049071-17-000001 · edgar.xml · derivative · entry 4

McDonald William J. · CIK 0001415604 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 785

Underlying: Humana Common · 143 shares

Expires not disclosed

F3 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

F3 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).

Read SEC document
December 31, 2016 Filed Jan 4, 2017 21:11 UTC GrantStock Unit · Derivative 153 $203.53 $31,140.09
Disclosure

SEC source: 0000049071-17-000001 · edgar.xml · derivative · entry 3

McDonald William J. · CIK 0001415604 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,846

Underlying: Humana Common · 153 shares

Expires not disclosed

F2 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F2 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
December 22, 2016 Filed Dec 23, 2016 18:11 UTC
MARGULIS HEIDI SSenior V.P. -Corporate Affairs
Exercise / conversionOptions · Derivative 4,971 $0.00 Strike: $164.65 $0.00
Disclosure

SEC source: 0000049071-16-000203 · edgar.xml · derivative · entry 7

MARGULIS HEIDI S · CIK 0001103605 · Senior V.P. -Corporate Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,942

Underlying: Humana Common · 4,971 shares

Expires 2022-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Right to buy pursuant to Humana Inc.'s 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18.

F3 · derivative.exercise_date: Right to buy pursuant to Humana Inc.'s 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18.

Read SEC document
December 22, 2016 Filed Dec 23, 2016 18:11 UTC
MARGULIS HEIDI SSenior V.P. -Corporate Affairs
Exercise / conversionOptions · Derivative 4,842 $0.00 Strike: $102.16 $0.00
Disclosure

SEC source: 0000049071-16-000203 · edgar.xml · derivative · entry 6

MARGULIS HEIDI S · CIK 0001103605 · Senior V.P. -Corporate Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,422

Underlying: Humana Common · 4,842 shares

Expires 2021-02-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Right to buy pursuant to Humana Inc.'s 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/14, vesting in three increments from 02/18/15 to 02/18/17.

F2 · derivative.exercise_date: Right to buy pursuant to Humana Inc.'s 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/14, vesting in three increments from 02/18/15 to 02/18/17.

Read SEC document
December 22, 2016 Filed Dec 23, 2016 18:11 UTC
MARGULIS HEIDI SSenior V.P. -Corporate Affairs
Exercise / conversionOptions · Derivative 1,936 $0.00 Strike: $72.84 $0.00
Disclosure

SEC source: 0000049071-16-000203 · edgar.xml · derivative · entry 5

MARGULIS HEIDI S · CIK 0001103605 · Senior V.P. -Corporate Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Humana Common · 1,936 shares

Expires 2020-02-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Right to buy pursuant to Humana Inc.'s 2003 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/20/13, vesting in three increments from 02/20/14 to 02/20/16.

F1 · derivative.exercise_date: Right to buy pursuant to Humana Inc.'s 2003 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/20/13, vesting in three increments from 02/20/14 to 02/20/16.

Read SEC document
December 22, 2016 Filed Dec 23, 2016 18:11 UTC
MARGULIS HEIDI SSenior V.P. -Corporate Affairs
Tax withholdingHumana Common 9,061 $200.81 $1,819,494.11
Disclosure

SEC source: 0000049071-16-000203 · edgar.xml · nonDerivative · entry 4

MARGULIS HEIDI S · CIK 0001103605 · Senior V.P. -Corporate Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,371

F8 · price: The total amount of shares withheld for taxes and swapped for purchase price is 9,061. The amount of shares required for swap on purchase price for shares exercised under the Company's 2011 Stock Incentive Plan was determined using a Fair Market Value ("FMV") of $199.84 on 12/21/2016, pursuant to the Plan. All shares withheld for taxes and shares required for swap under the Company's 2003 Stock Incentive Plan were determined using the FMV on 12/22/2016 $200.8050, pursuant to each Plan.

Read SEC document
December 22, 2016 Filed Dec 23, 2016 18:11 UTC
MARGULIS HEIDI SSenior V.P. -Corporate Affairs
Exercise / conversionHumana Common 4,971 $164.65 $818,450.30
Disclosure

SEC source: 0000049071-16-000203 · edgar.xml · nonDerivative · entry 3

MARGULIS HEIDI S · CIK 0001103605 · Senior V.P. -Corporate Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,432

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 22, 2016 Filed Dec 23, 2016 18:11 UTC
MARGULIS HEIDI SSenior V.P. -Corporate Affairs
Exercise / conversionHumana Common 4,842 $102.16 $494,634.51
Disclosure

SEC source: 0000049071-16-000203 · edgar.xml · nonDerivative · entry 2

MARGULIS HEIDI S · CIK 0001103605 · Senior V.P. -Corporate Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,461

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 22, 2016 Filed Dec 23, 2016 18:11 UTC
MARGULIS HEIDI SSenior V.P. -Corporate Affairs
Exercise / conversionHumana Common 1,936 $72.84 $141,018.24
Disclosure

SEC source: 0000049071-16-000203 · edgar.xml · nonDerivative · entry 1

MARGULIS HEIDI S · CIK 0001103605 · Senior V.P. -Corporate Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,619

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 20, 2016 Filed Dec 22, 2016 14:57 UTC
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
Exercise / conversionOptions · Derivative 8,500 $0.00 Strike: $81.80 $0.00
Disclosure

SEC source: 0000049071-16-000202 · edgar.xml · derivative · entry 3

BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,581

Underlying: Humana Common · 8,500 shares

Expires 2020-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Right to buy pursuant to Humana Inc.'s 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 06/17/13, vesting in three increments from 06/17/14 to 06/17/16.

F1 · derivative.exercise_date: Right to buy pursuant to Humana Inc.'s 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 06/17/13, vesting in three increments from 06/17/14 to 06/17/16.

Read SEC document
December 20, 2016 Filed Dec 22, 2016 14:57 UTC
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
Tax withholdingHumana Common 5,972 $201.26 $1,201,924.72
Disclosure

SEC source: 0000049071-16-000202 · edgar.xml · nonDerivative · entry 2

BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,788

F8 · price: The total amount of shares withheld for taxes and swapped for purchase price is 5,960. The amount of shares required for swap on purchase price for shares exercised under the Company's 2011 Stock Incentive Plan was determined using a Fair Market Value ("FMV") of $202.9150 on 12/19/2016, pursuant to the Plan. Shares withheld for taxes was determined using the FMV on 12/20/2016 ($201.260), pursuant to the Plan.

Read SEC document
December 20, 2016 Filed Dec 22, 2016 14:57 UTC
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
Exercise / conversionHumana Common 8,500 $81.80 $695,257.50
Disclosure

SEC source: 0000049071-16-000202 · edgar.xml · nonDerivative · entry 1

BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,760

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2016 Filed Dec 19, 2016 20:21 UTC
LeClaire Brian P.SVP & Chief Information Off.
Exercise / conversionRestricted Stock Units · Derivative 1,092 $0.00 $0.00
Disclosure

SEC source: 0000049071-16-000200 · edgar.xml · derivative · entry 9

LeClaire Brian P. · CIK 0001528285 · SVP & Chief Information Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,186

Underlying: Humana Common · 1,092 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F6 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F8 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18.

F8 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18.

Read SEC document
December 15, 2016 Filed Dec 19, 2016 20:21 UTC
LeClaire Brian P.SVP & Chief Information Off.
Tax withholdingHumana Common 548 $206.60 $113,214.06
Disclosure

SEC source: 0000049071-16-000200 · edgar.xml · nonDerivative · entry 2

LeClaire Brian P. · CIK 0001528285 · SVP & Chief Information Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,845

Read SEC document
December 15, 2016 Filed Dec 19, 2016 20:21 UTC
LeClaire Brian P.SVP & Chief Information Off.
Exercise / conversionHumana Common 1,092 $0.00 $0.00
Disclosure

SEC source: 0000049071-16-000200 · edgar.xml · nonDerivative · entry 1

LeClaire Brian P. · CIK 0001528285 · SVP & Chief Information Off.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,393

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2016 Filed Dec 19, 2016 20:31 UTC
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 1,092 $0.00 $0.00
Disclosure

SEC source: 0000049071-16-000201 · edgar.xml · derivative · entry 8

BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,186

Underlying: Humana Common · 1,092 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18.

F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18.

Read SEC document
December 15, 2016 Filed Dec 19, 2016 20:31 UTC
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
Tax withholdingHumana Common 551 $206.60 $113,833.85
Disclosure

SEC source: 0000049071-16-000201 · edgar.xml · nonDerivative · entry 2

BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,260

Read SEC document
December 15, 2016 Filed Dec 19, 2016 20:31 UTC
BEVERIDGE, ROY ASr. VP & Chief Medical Officer
Exercise / conversionHumana Common 1,092 $0.00 $0.00
Disclosure

SEC source: 0000049071-16-000201 · edgar.xml · nonDerivative · entry 1

BEVERIDGE, ROY A · CIK 0001579300 · Sr. VP & Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,811

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2016 Filed Dec 19, 2016 20:16 UTC
Kane Brian ASVP & Chief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 1,539 $0.00 $0.00
Disclosure

SEC source: 0000049071-16-000199 · edgar.xml · derivative · entry 6

Kane Brian A · CIK 0001609525 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,079

Underlying: Humana Common · 1,539 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F3 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18

F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18

Read SEC document
December 15, 2016 Filed Dec 19, 2016 20:16 UTC
Kane Brian ASVP & Chief Financial Officer
Tax withholdingHumana Common 541 $206.60 $111,767.90
Disclosure

SEC source: 0000049071-16-000199 · edgar.xml · nonDerivative · entry 2

Kane Brian A · CIK 0001609525 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 998

Read SEC document
December 15, 2016 Filed Dec 19, 2016 20:16 UTC
Kane Brian ASVP & Chief Financial Officer
Exercise / conversionHumana Common 1,539 $0.00 $0.00
Disclosure

SEC source: 0000049071-16-000199 · edgar.xml · nonDerivative · entry 1

Kane Brian A · CIK 0001609525 · SVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,539

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2016 Filed Dec 19, 2016 19:53 UTC Exercise / conversionRestriced Stock Units · Derivative 2,383 $0.00 $0.00
Disclosure

SEC source: 0000049071-16-000198 · edgar.xml · derivative · entry 12

MURRAY JAMES E · CIK 0001018658 · EVP & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,768

Underlying: Humana Common · 2,383 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F9 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18.

F9 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18.

Read SEC document
December 15, 2016 Filed Dec 19, 2016 19:53 UTC Tax withholdingHumana Common 1,180 $206.60 $243,782.10
Disclosure

SEC source: 0000049071-16-000198 · edgar.xml · nonDerivative · entry 2

MURRAY JAMES E · CIK 0001018658 · EVP & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,441

Read SEC document
December 15, 2016 Filed Dec 19, 2016 19:53 UTC Exercise / conversionHumana Common 2,383 $0.00 $0.00
Disclosure

SEC source: 0000049071-16-000198 · edgar.xml · nonDerivative · entry 1

MURRAY JAMES E · CIK 0001018658 · EVP & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,621

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2016 Filed Dec 19, 2016 19:41 UTC
MARGULIS HEIDI SSenior V.P. -Corporate Affairs
Exercise / conversionRestricted Stock Units · Derivative 1,092 $0.00 $0.00
Disclosure

SEC source: 0000049071-16-000197 · edgar.xml · derivative · entry 8

MARGULIS HEIDI S · CIK 0001103605 · Senior V.P. -Corporate Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,186

Underlying: Humana Common · 1,092 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F5 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F7 · derivative.exercise_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18.

F7 · derivative.expiration_date: Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18.

Read SEC document
December 15, 2016 Filed Dec 19, 2016 19:41 UTC
MARGULIS HEIDI SSenior V.P. -Corporate Affairs
Tax withholdingHumana Common 537 $206.60 $110,941.52
Disclosure

SEC source: 0000049071-16-000197 · edgar.xml · nonDerivative · entry 2

MARGULIS HEIDI S · CIK 0001103605 · Senior V.P. -Corporate Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,683

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.